Disc Medicine, Inc. - 8-K Filing
Disc Medicine reported Q2 financial results with $718M cash runway into 2029, and provided updates on clinical trials including APOLLO topline data expected in Q4. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $IRON